| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |